IndraLab

Statements

USP10 inhibits Insulin Resistance. 5 / 5
| 4 1
eidos
"It has been demonstrated that USP10 inhibits hepatic steatosis and insulin resistance via Sirt6 , in which Sirt6 represses the transcription levels of SREBP1 / SREBP2 and their target genes [ 114 ] ."
33622377
eidos
"31 Recently , a report suggested that USP10 can inhibit hepatic steatosis , insulin resistance , and inflammation through Sirt6 in nonalcoholic fatty liver disease ."
33170082
reach
"For example, USP10 expression is decreased and upregulated in hepatic steatosis models to inhibit hepatic steatosis, insulin resistance, and inflammation [7]."
34412625
eidos
"In a non-alcoholic fatty liver disease model , USP10 inhibits hepatic steatosis , insulin resistance , and the inflammatory response by interacting with SIRT6 and inhibiting its ubiquitination and degradation ( 6 ) , and USP10 inhibition also abolishes Mirt2 ( long non-coding RNA myocardial infarction associated transcript 2 ) overexpression-induced suppression of glucose production and lipogenesis in hepatocytes ( 7 ) ."
33133065
eidos
"For example , USP10 expression is decreased and upregulated in hepatic steatosis models to inhibit hepatic steatosis , insulin resistance , and inflammation [ 7 ] ."
34412625